The Scientist

» drug development, culture and ecology

Most Recent

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

image: Parallel Plagues

Parallel Plagues

By | April 1, 2016

Like cancer, ecological scourges result from the breakdown of regulatory processes, and may be treated with similar logic.

0 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2016

April 2016's selection of notable quotes

0 Comments

image: Another Drug Price Hike

Another Drug Price Hike

By | March 28, 2016

Valeant Pharmaceuticals is criticized for jacking up the price of a drug used in assisted suicide.

0 Comments

image: Book Review: <em>Personal Trials</em>

Book Review: Personal Trials

By | March 22, 2016

At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.

0 Comments

image: The 2016 Salary Survey Is Here

The 2016 Salary Survey Is Here

By | March 18, 2016

Answer some brief questions and help us determine the most current salary outlook for life scientists and earn a chance to win a $100 Amazon gift card.

0 Comments

image: Cannabis-Based Drug for Epilepsy

Cannabis-Based Drug for Epilepsy

By | March 14, 2016

A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 

0 Comments

image: Student Fights Harassment with Wikipedia

Student Fights Harassment with Wikipedia

By | March 10, 2016

Every time Emily Temple-Wood receives an inappropriate email, she writes a Wikipedia entry about a woman scientist.

8 Comments

A study suggests bats in Asia could have genes that protect them from the fungal infection that is decimating bat populations in North America.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | March 1, 2016

Herding Hemingway's Cats, Hair: A Human History, Restless Creatures, and The Mind Club

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech